Use of chromogenic in-situ hybridization (CISH) in determining Her2 status

被引：0
|
作者：
Jundi, M [1 ]
Selim, S [1 ]
Phillips, S [1 ]
Garcia, FU [1 ]
机构：
[1] Drexel Univ, Sch Med, Philadelphia, PA 19104 USA
来源：
LABORATORY INVESTIGATION | 2003年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
145
引用
收藏
页码：35A / 35A
页数：1
相关论文
共 50 条
  • [41] Comparison of chromogenic in situ hybridization with other methodologies for HER2 status assesment in breast cancer
    Hauser-Kronberger, C
    Dandachi, N
    [J]. JOURNAL OF MOLECULAR HISTOLOGY, 2004, 35 (06) : 647 - 653
  • [42] Evaluation of HER2 gene status in breast cancer by chromogenic in situ hybridization:: Comparison with immunohistochemistry
    Kounelis, S
    Kapranos, N
    Malamos, N
    Kouri-Bairaktari, E
    [J]. ANTICANCER RESEARCH, 2005, 25 (2A) : 939 - 946
  • [43] HER2 Status Determined on Pre Operative Biopsies and in Operative Specimens: Concordance among Immunohistochemistry (IHC) Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH) Techniques in the CRITHER Study
    Roger, P.
    Lannes, B.
    Balaton, A.
    Hayem, C.
    Campana, F.
    Arnould, L.
    Penault-Llorca, F.
    MacGrogan, G.
    [J]. MODERN PATHOLOGY, 2009, 22 : 65A - 65A
  • [44] Chromogenic in situ hybridisation (CISH) should be an accepted method in the routine diagnostic evaluation of HER2 status in breast cancer
    Di Palma, S.
    Collins, N.
    Faulkes, C.
    Ping, B.
    Ferns, G.
    Haagsma, B.
    Layer, G.
    Kissin, M. W.
    Cook, M. G.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (09) : 1067 - 1068
  • [45] Comparison of fluorescence in situ hybridization and dual colour chromogenic in situ hybridization for the assessment of HER2 status on gastric cancer biopsies
    Gomez-Martin, C.
    Garcia-Garcia, E.
    Suarez-Gauthier, A.
    Conde, E.
    Lopez-Rios, F.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 404 - 404
  • [46] HER2 Status Determined on Pre Operative Biopsies and in Operative Specimens: Concordance among Immunohistochemistry (IHC) Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH) Techniques in the CRITHER Study
    Roger, P.
    Lannes, B.
    Balaton, A.
    Hayene, C.
    Campana, F.
    Arnould, L.
    Penault-Llorca, F.
    MacGrogan, G.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 65A - 65A
  • [47] HER2 status determined on pre operative biopsies and inoperative specimens: concordance among immunohistochemistry (IHC) fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH) techniques in the CRITHER study
    Arnould, L.
    Roger, P.
    MacGrogan, G.
    Lannes, B.
    Hayem, C.
    Campana, F.
    Balaton, A.
    Penault-Llorca, F.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 132S - 133S
  • [48] Putting the colours into chromogenic in situ hybridization (CISH)
    Shipley, J.
    [J]. JOURNAL OF PATHOLOGY, 2006, 210 (01): : 1 - 2
  • [49] Comparison of chromogenic in-situ hybridisation (CISH) with FISH and IHC for assessment of HER2 status and prediction of response to therapy: Analysis from a study of trastuzumab monotherapy
    Hofmann, Manfred
    Gaiser, Timo
    Kneitz, Hermann
    Weng, Le Phuong
    Schmidtgen, Claudia
    Gutjahr, Thorsten
    Gross, Christof
    Henkel, Thomas
    Rueschoff, Josef
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 15 - 15
  • [50] Comparison Between Dual- and Single-Probe Chromogenic In Situ Hybridization (CISH) in Assessing HER2 Gene Status of Chinese Breast Cancer Patients
    Nie, Xiu
    He, Jun
    Han, Mark
    Bai, Chenguang
    Bai, Chenguang
    Huang, Tao
    Ni, Canrong
    Yang, Xiuping
    Chen, Jinsu
    Zheng, Weiqiang
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (04) : 672 - 672
12345